Abstract
Hyperglycemia on admission to the coronary care unit is associated with poor outcome. It has now been reasonably well established that intravenous insulin infusion during acute myocardial infarction has a protective role and reduces mortality. The present article reviews the current understanding of the cardioprotective effect of insulin and the recent advances in this area.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Coronary Care Units
-
Critical Care / methods
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Hyperglycemia / drug therapy*
-
Hyperglycemia / etiology
-
Hyperglycemia / mortality
-
Infusions, Intravenous
-
Insulin / therapeutic use*
-
Male
-
Myocardial Infarction / complications*
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / mortality
-
Myocardial Ischemia / physiopathology
-
Prognosis
-
Risk Assessment
-
Severity of Illness Index
-
Survival Analysis
-
Treatment Outcome